CONCOMITANT USE OF CORTICOSTEROIDS AT THE BASELINE DOES NOT AFFECT THE DRUG SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS

dc.contributor.authorKoca, S. S.
dc.contributor.authorOz, B.
dc.contributor.authorKaratas, A.
dc.contributor.authorDalkilic, H. E.
dc.contributor.authorCan, G.
dc.contributor.authorPehlivan, Y.
dc.contributor.authorOnen, F.
dc.date.accessioned2026-08-12T18:12:29Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.descriptionCongress of the European-League-Against-Rheumatism (EULAR) -- JUN 13-16, 2018 -- Amsterdam, NETHERLANDS
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean League Against Rheumatism
dc.identifier.doi10.1136/annrheumdis-2018-eular.5819
dc.identifier.endpage597
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.orcid0000-0003-2167-4509
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.orcid0000-0001-5118-9307
dc.identifier.orcid0000-0001-8347-0873
dc.identifier.startpage597
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2018-eular.5819
dc.identifier.urihttps://hdl.handle.net/11508/63904
dc.identifier.volume77
dc.identifier.wosWOS:000444351001568
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleCONCOMITANT USE OF CORTICOSTEROIDS AT THE BASELINE DOES NOT AFFECT THE DRUG SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS
dc.typeConference Object

Dosyalar